COMPLETED

Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's Disease

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to evaluate a comprehensive model for integrating both primary and specialty Palliative Care for older adults with dementia into nursing facilities. Palliative Care is a supportive care approach that aims to improve the quality of life of patients and their families facing serious or life-threatening illnesses, through the prevention and relief of suffering through the treatment of pain and other problems, using physical, psychosocial and spiritual approaches. Palliative care is specialized medical care for people who are living with a serious illness. This type of care is focused on providing relief from the symptoms and from the stress of the illness. The goal is to improve quality of life for both patient and family. The UPLIFT-AD model will include providing education on primary Palliative Care for residents with dementia to nursing facility staff, training nursing facility staff in providing primary Palliative Care, and providing access to specialty Palliative Care consultations for residents. To help understand the impact of these interventions, this study will also collect information about resident health, the care they receive, and perceptions of their quality of life according to both family members and nursing facility staff.

Official Title

Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's Disease

Quick Facts

Study Start:2021-09-08
Study Completion:2025-09-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT04520698

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Long-stay resident in an enrolled nursing home defined as not paying through Medicare Part A at the enrolled facility.
  2. * Has a diagnosis of moderate to severe ADRD, as measured on the Minimum Data Set (MDS)
  3. * Length of stay \>30 days
  4. * Family member and/or surrogate decision maker for an eligible resident in an enrolled nursing home
  5. * English-speaking
  6. * Staff, nurse, or nurse assistant in an enrolled nursing facility
  7. * English-speaking
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Principal Investigator

Kathleen T Unroe, MD, MHA
PRINCIPAL_INVESTIGATOR
Indiana University
John Cagle, PhD, MSW
PRINCIPAL_INVESTIGATOR
University of Maryland, Baltimore

Study Locations (Sites)

American Senior Communities
Indianapolis, Indiana, 46201
United States

Collaborators and Investigators

Sponsor: Indiana University

  • Kathleen T Unroe, MD, MHA, PRINCIPAL_INVESTIGATOR, Indiana University
  • John Cagle, PhD, MSW, PRINCIPAL_INVESTIGATOR, University of Maryland, Baltimore

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-09-08
Study Completion Date2025-09-30

Study Record Updates

Study Start Date2021-09-08
Study Completion Date2025-09-30

Terms related to this study

Keywords Provided by Researchers

  • Alzheimer Disease
  • Palliative Care
  • Dementia
  • Nursing Home

Additional Relevant MeSH Terms

  • Alzheimer Disease